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Abstract
Background: Human phospholipid scramblase 1 (hPLSCR1) was initially identified as a Ca2+ dependent
phospholipid translocator involved in disrupting membrane asymmetry. Recent reports revealed that hPLSCR1 acts
as a multifunctional signaling molecule rather than functioning as scramblase. hPLSCR1 is overexpressed in a variety
of tumor cells and is known to interact with a number of protein molecules implying diverse functions.
Results: In this study, the nuclease activity of recombinant hPLSCR1 and its biochemical properties have been
determined. Point mutations were generated to identify the critical region responsible for the nuclease activity.
Recombinant hPLSCR1 exhibits Mg2+ dependent nuclease activity with an optimum pH and temperature of 8.5 and
37 °C respectively. Experiments with amino acid modifying reagents revealed that histidine, cysteine and arginine
residues were crucial for its function. hPLSCR1 has five histidine residues and point mutations of histidine residues
to alanine in hPLSCR1 resulted in 60 % loss in nuclease activity. Thus histidine residues could play a critical role in
the nuclease activity of hPLSCR1.
Conclusions: This is the first report on the novel nuclease activity of the multi-functional hPLSCR1. hPLSCR1 shows
a metal dependent nuclease activity which could play a role in key cellular processes that needs to be further
investigated.
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Background
Human phospholipid scramblases (hPLSCRs) are type II
single pass transmembrane proteins involved in the Ca2+
dependent ATP independent translocation of phospho-
lipids (PLs) across the lipid bilayer [1]. hPLSCR1 was first
identified as a 37 kDa integral membrane protein from
human erythrocytes, which was capable of bidirectional
scrambling of PLs between two leaflets of the lipid bilayer
when reconstituted into liposomes. The gene encoding
hPLSCR1 was cloned, overexpressed and the recombinant
hPLSCR1 exhibited low scrambling activity compared to
that of erythrocyte PL scramblase [1]. Five homologs of
scramblases (hPLSCR1–5) have been identified so far.
hPLSCR1, 3 and 4 were expressed in wide variety of tissues;
whereas hPLSCR2 was found only in testis and hPLSCR5
has been shown only at mRNA level [2, 3].
hPLSCR1 possesses a single transmembrane helix but
can localize to both plasma membrane (PM) and nucleus.
It has been reported that scramblases destroy the lipid
asymmetry in PM when intracellular Ca2+ levels were
elevated by 1000 fold [1]. Previous studies showed that
phosphatidylserine (PS) exposure during apoptotic condi-
tions was directly related to hPLSCR1 expression levels and
the amount of PS exposed to the cell surface could be ma-
nipulated by modifying the expression levels of hPLSCR1
[4]. Subsequent reports have questioned the role of
hPLSCR1 in PS exposure [5–9]. Recently, a member of Ca2
+ dependent ion channels, TMEM16F, and members of Xkr
protein family were identified to be responsible for
phospholipid scrambling in plasma membrane [10–13].
These reports along with other unusual factors for PL
translocators such as low molecular weight, single trans-
membrane domain and slow rate of PL scrambling in-vitro
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support the argument that hPLSCR1 may not be a true
scramblase and can have varied roles within the cell apart
from phospholipid scrambling.
hPLSCR1 is a multifunctional protein involved in
several other cellular processes including cell signaling,
cell proliferation, transcriptional regulation and antiviral
defense [14–18]. Overexpression of hPLSCR1 in myeloid
cells inhibited tumorigenesis and enhanced cell differenti-
ation [19, 20]. hPLSCR1 interacts with variety of signaling
molecules such as epidermal growth factor receptor, c-Abl,
Src kinase, Shc and onzins [21–23]. hPLSCR1 also interacts
with nuclear proteins including importin-α and topoisom-
erase II [24, 25] and was shown to exhibit high affinity to
chromatin [26]. hPLSCR1 expression is strongly stimulated
in response to interferons and viral infections [6, 14]. Inter-
ferons are well known to stimulate the expression of several
nucleases as a part of antiviral defense [27]. hPLSCR1
inhibits Hepatitis B virus replication partly by activating the
Jak/Stat pathway [28]. hPLSCR1 interacts with Human T-
cell leukemia virus type-1 (HTLV-1) and represses the Tax-
dependent transactivation during HTLV-1 infection [29].
hPLSCR1 is characterized by five distinct domains con-
served across the species: (i) C- terminal helix that spans
the plasma membrane and is responsible for activity; (ii)
Cysteine palmitoylation motif which helps in anchoring the
protein to the membrane; (iii) Nuclear localization signal
which helps in nuclear transport; (iv) an EF hand like Ca2+
binding motif and (v) DNA binding domain (M86-E118) [3].
The EF hand like Ca2+ binding motif is vital for Ca2+ bind-
ing and scramblase activity of hPLSCR1. Mutations in this
motif rendered the protein inactive as the protein lost its
ability to bind to calcium [30]. In a previous study, we
showed that apart from Ca2+ binding to the EF-hand like
motif, hPLSCR1 could also bind to a variety of metal ions
including Mg2+ [31]. The DNA binding domain was shown
to bind with the promoter of inositol 3-phosphate receptor
(IP3R), enhancing the expression of IP3R [32]. Recently we
identified a unique N-terminal proline rich domain (PRD)
in hPLSCR1 and showed that the PRD is essential for the
oligomerization and functional activation of hPLSCR1 [33].
hPLSCR1 interacts with c-terminal domain (CTD) of
topoisomerase IIα (topo IIα) and enhances its decatena-
tion activity [25]. The mechanism of the enhancement
of topo IIα catalytic activity by hPLSCR1 is not yet
understood. We hypothesize that the mechanism of
enhancement of the activity of topo IIα by hPLSCR1
could happen in two ways: (i) hPLSCR1 helps in
unwinding or cleaving of catenated substrate for the
topo IIα to subsequently decatenate; (ii) hPLSCR1 might
have independent nuclease properties that could
compliment the decatenation activity of topo IIα.
Based on the ability of hPLSCR1 to bind to DNA and
Mg2+, cytoplasmic localization, stimulation by interferons,
and enhancement of decatenation activity of topo IIα, we
believed that hPLSCR1 could moonlight as a metal ion
dependent nuclease. In this study, we have shown that
recombinant hPLSCR1 exhibits nuclease properties con-
tributing to a novel feature of this multifunctional protein.
Methods
Overexpression and purification of hPLSCR1
hPLSCR1 cDNA clone was obtained from Origene, MD,
USA, and was subsequently cloned into pET-28a (+)
bacterial expression vector with an N-terminal His tag. This
was transformed into E. coli BL-21 (DE3) and grown in LB
media containing kanamycin (50 mg/l). Overexpression
and purification were performed as described earlier [34].
Briefly, cells were lysed in buffer (20 mM Tris–HCl (pH –
7.4), 200 mM NaCl) by sonication, hPLSCR1 formed
inclusion bodies (IB). N- lauroylsarcosine (N-LS) was used
to recover native protein from IB followed by dialysis to
remove N-LS and the proteins were purified to homogen-
eity using Ni2+-NTA chromatography. The eluted fractions
from Ni2+-NTA chromatography were subjected to anion-
exchange chromatography where DEAE sepharose (GE
Healthcare, LC, UK) was used. The NaCl eluted protein
fractions were again loaded in Ni2+-NTA resin and eluted.
The purified protein was further concentrated by Amicon
centrifugal filters (10 kDa cut-off) (Millipore, MA, USA)
and visualized by silver staining or coomassie staining and
confirmed by western blotting using anti-hPLSCR1 mono-
clonal antibody (Name: PLSCR1 antibody 1E9; catalog no -
sc59645; specificity -human; origin - mouse monoclonal
IgG1, Santa Cruz Biotechnology, TX, USA).
Generation of point mutant of hPLSCR1
Overlap PCR method was used to generate point mu-
tations in hPLSCR1 where the 5 histidines (H12, H53,
H111, H2111, H262) were mutated to alanine and
was subsequently cloned in pET28a (+), confirmed by
sequencing and named as Mut-hPLSCR1. Overexpres-
sion and purification of Mut-hPLSCR1 were done as
described earlier. Briefly, mutagenic primers were syn-
thesized to incorporate the specific point mutations
(Fig. 8a). Using wild type hPLSCR1 gene as a tem-
plate, PCR was performed with the following combi-
nations of primers to produce 6 fragments and
named as follows. Stage 1 PCR: Fragment 1 - F1, R6;
Fragment 2 - F2, R5; Fragment 3 - F3, R4; Fragment
4 - F4, R3; Fragment 5 -F5, R2; Fragment 6 – F6, R1.
Stage 2 PCR: Adjacent fragments are used as a tem-
plate with appropriate primers as follows. Initial 10 cy-
cles of PCR were performed without the primers after
which the primers were added; Fragment A - Frag-
ment 1 + Fragment 2 – Primers – F1 and R5; Frag-
ment B - Fragment 3 + Fragment 4 – Primers – F3
and R3; Fragment C – Fragment 5 + Fragment 6 –
Primers – F5 and R1; Stage 3 PCR: Fragment I –
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Fragment A + Fragment B – Primers F1 and R3; Frag-
ment II – Fragment B + Fragment C – Primers F3
and R1. Stage 4 PCR: Mutant hPLSCR1 – Fragment I
+ Fragment II – Primers F1 and R1.
Decatenation assay
Decatenation assay was performed using the topo II
decatenation assay kit (Topogen, CO, USA) as per
manufacturer’s instructions. Briefly, 200 ng of kineto-
plast DNA (kDNA) in standard Topo assay buffer
(50 mM Tris–HCl (pH - 8.0), 150 mM NaCl, 10 mM
MgCl2 and 0.5 mM dithiothreitol) was treated with 1
U of topo IIα pretreated with hPLSCR1 (30 min, 4 °
C) and incubated for 15 min at 37 °C. Negative con-
trol has only the kDNA but not the enzyme. The
products were visualized on a 1 % agarose gel stained
with ethidium bromide.
Nuclease activity: gel assay
Nuclease assays were performed with 20 pmol of
purified recombinant hPLSCR1, 200 ng of yeast/ hu-
man genomic DNA as substrate in the assay buffer
containing 50 mM Tris–HCl (pH - 8.0), 150 mM
NaCl, 10 mM MgCl2 and 0.5 mM dithiothreitol to a
total volume of 20 μl and incubated at 37 °C for
1 h. The reaction products were separated by elec-
trophoresis on 1 % agarose gel with ethidium brom-
ide (0.5 μg/ml); 12 % native PAGE stained with
ethidium bromide was also used to visualize the
products of the nuclease reaction.
Nuclease activity: Kunitz assay
Kunitz assays were performed with 1 pmol/μl of puri-
fied recombinant hPLSCR1, 50 μg/ml of calf thymus
DNA (Sigma Aldrich, USA) as the substrate in a buf-
fer containing 50 mM Tris–HCl (pH - 8.0), 150 mM
NaCl, 10 mM MgCl2 and 0.5 mM dithiothreitol to a
total volume of 500 μl and incubated at 37 °C for
15 min. Negative controls contained only the DNA
substrate without hPLSCR1. The difference in A260
between control and sample was considered for meas-
uring the nuclease activity. One Kunitz unit is defined
as the amount of enzyme added to 1 mg/ml of DNA
that causes an increase in absorbance of 0.001 per
minute at 260 nm at 37 °C. The increase in absorb-
ance is due to the release of free nucleotides upon
degradation of polymerized DNA [35]. Briefly, the en-
zyme activity is quantified as follows.
Amount of DNA : 25 μg (final concentration – 50 μg/
ml)
Dilution factor : 20
Amount of protein : 1 pmol/μl
Incubation time : 15 min
Test : DNA treated with hPLSCR1
Control : Untreated DNA
Enzyme activity ¼ A260 testð Þ−A260 controlð Þ½   20
0:001 15
Protease treatment and heat inactivation of hPLSCR1
hPLSCR1 was either heat inactivated by incubating at
65 °C for 15 min or treated with trypsin for 60 min at
37 °C and then used for the nuclease assays and Kunitz
assays as described earlier. Mock treated hPLSCR1 was
used as a positive control.
Effect of various parameters on nuclease activity
Nuclease assays were performed as described earlier
with varying incubation times such as 5, 10, 15, 30, 60,
90 min respectively and were analyzed on a 1 % agarose
gel stained with ethidium bromide. Nuclease assay was
also performed at various enzyme concentrations and vi-
sualized on a 1 % agarose gel as described earlier. Vari-
ous substrates such as RNA, linear dsDNA, ssDNA and
plasmid DNA were used for nuclease assay to identify
the specificity of nuclease activity of hPLSCR1. The ef-
fect of temperature on nuclease activity was observed by
performing assays at 25 °C, 30 °C, 37 °C, 40 °C, 45 °C
and 50 °C and incubated for 60 min for nuclease assay
or 15 min for Kunitz assay. Nuclease assays were per-
formed at various pH ranging from 4.5 to 9.5 with pH 8
as the reference pH and were quantified using Kunitz
assay or visualized on 1 % agarose gel as described earl-
ier. Effect of metal ions on nuclease activity was studied
by performing nuclease assays using an assay buffer
without MgCl2 and adding 10 mM of MgCl2, 10 mM of
CaCl2 and 10 mM of ZnCl2 respectively. Dose
dependent studies were also performed for Ca2+, Mg2+
and Zn2+ (5 mM, 10 mM, 15 mM, and 20 mM). Nucle-
ase assays and Kunitz assays were set up in the presence
and absence of 4 mM of different amino acid modifiers
namely, N-ethylmaleimide (NEM), 4-(2-aminoethyl)
benzenesulfonyl fluoride hydrochloride (AEBSF), diethyl
pyrocarbonate (DEPC), phenyl glyoxal (PG). The reac-
tion mixtures were incubated at 37 °C for 60 min and
analyzed on a 1 % agarose gel. Dose dependent Kunitz
assays were performed for hPLSCR1 with 2 mM, 4 mM,
8 mM and 16 mM of DEPC.
Circular Dichroism studies
Circular Dichroism (CD) studies were performed with a
JASCO J-810 spectropolarimeter (Jasco, MD, USA). Far
UV-CD spectra were recorded at 25 °C with a thermo-
stat cell holder. 10 μM of protein in assay buffer was
used for the scan with increasing concentrations of
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MgCl2. Samples were scanned using 1 mm path length
cuvettes from 250 to 190 nm.
Statistical analysis
Data represented was statistically analyzed using Student’s
t-test and p < 0.01 was considered to be significant.
Results
Overexpression and purification of recombinant hPLSCR1
Recombinant hPLSCR1 was overexpressed in E. coli
BL21 (DE3) and purified to homogeneity as described in
the literature [34]. The purification steps are shown in
the schematic (Fig. 1a). Briefly, hPLSCR1-pET28a (+)
was transformed in E. coli BL21 (DE3) cells and induced
with IPTG for overexpression. Upon sonication, the
hPLSCR1 localized as inclusion bodies (IB) (Lane 5,
Fig. 1b) with little or no protein in the soluble fraction
(Lane 4, Fig. 1b). The IBs were treated with N-
Lauroylsarcosine (N-LS), which recovered active protein
from IBs to the soluble fraction (Lane 6, Fig. 1b). The
N-LS was removed by pulse dialysis as described earlier
[34] and N-LS removed protein was purified by His tag -
Ni2+-NTA chromatography (Fig. 1c). The eluted frac-
tions were dialyzed against purification buffer (20 mM
Tris–HCl (pH-7.4), 200 mM NaCl) to remove imidazole
and then passed through DEAE sepharose column.
Fig. 1 Overexpression and purification of recombinant hPLSCR1 in E. coli BL21 (DE3). a Schematic showing the steps involved in recombinant purification
of hPLSCR1 b Coomassie stained SDS-PAGE gel showing hPLSCR1 at each stage of purification: Recombinant hPLSCR1 was overexpressed in E. coli BL21
(DE3) and seen as an intense band in lane 3, compared to the uninduced cells (Lane 2). The cells were then lysed by sonication. Most of the overexpressed
protein was extracted as inclusion bodies (Lane 5) with low amounts in the soluble fraction (Lane 4). N-Lauroylsarcosine recovered active protein from the
inclusion bodies into the soluble fraction (Lane 6). c Silver stained SDS-PAGE gel showing purified hPLSCR1: The N-LS recovered protein was purified to
homogeneity by Ni2+ - NTA chromatography and the elutes were loaded on to 12 % SDS PAGE. d DEAE anion exchange chromatography was performed
for the elutes from Ni2+-NTA chromatography and then eluted with a NaCl gradient. hPLSCR1 eluted in 350 mM NaCl (Lane 5–8). e The 350 mM DEAE
fractions containing hPLSCR1 were pooled and again passed through Ni2+-NTA resin and eluted with 250 mM imidazole. The eluted samples were then
concentrated and estimated. Left panel shows the silver stained SDS-PAGE gel showing 20 pmol and 200 pmol of purified hPLSCR1. Western blotting was
performed for the purified hPLSCR1, where a specific monoclonal antibody against hPLSCR1 was used and visualized by chemiluminescence as shown in
the right panel
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hPLSCR1 was eluted at 350 mM of NaCl and the eluted
fractions were then loaded again onto a Ni2+-NTA col-
umn (Fig. 1d). In order to enhance the purity, His-tag
purification was repeated. Finally, the protein was con-
centrated using centrifugal filters and protein content
was estimated by BCA method. To confirm the purity,
200 pmol (10 times higher than used in nuclease assay)
of the purified protein was loaded on a 12 % SDS-PAGE
(silver staining). A single band corresponding to 37 kDa
clearly showed that the purified protein does not have
other contaminant proteins (Fig. 1e, left panel). The
purified protein was further confirmed by western blotting
using anti-hPLSCR1 antibody. A single band correspond-
ing to hPLSCR1 was visualized confirming that the puri-
fied recombinant protein was indeed hPLSCR1 (Fig. 1e,
right panel).
Decatenation assay for topo IIα in the presence of
hPLSCR1
hPLSCR1 is known to interact and enhance the decate-
nation activity of topo IIα. hPLSCR1 could enhance the
decatenation activity of topo IIα by either aiding in
unwinding and cleaving of the substrate DNA bound to
topo IIα or could have independent nuclease properties
which could compliment the decatenation activity of
topo IIα. To understand the characteristics of this inter-
action, we performed decatenation assay for topo IIα in
the presence of hPLSCR1. When low amount (2 pmol) of
hPLSCR1 was added, decatenation activity of topo IIα was
enhanced (Lane 1, Fig. 2) but when the hPLSCR1 concen-
tration was increased (20 pmol), apart from enhancement
of decatenation activity, a new distinct band was observed
(Lane 2, Fig. 2). This was further confirmed by performing
the decatenation assay in the absence of topo IIα (Lane 3,
Fig. 2). Results showed presence of the distinct band when
only hPLSCR1 was added, thereby revealing that hPLSCR1
processes kDNA independently of topo IIα and could
possess nuclease properties (Fig. 2).
Nuclease activity of hPLSCR1
In-vitro nuclease assays were done by incubating 20
pmol of hPLSCR1 with 200 ng of genomic DNA as sub-
strate for 60 min at 37 °C. Yeast genomic DNA and hu-
man genomic DNA were used as substrates for the
nuclease reaction (Fig. 3a). Presence of nuclease activity
was confirmed by the disappearance of the band imply-
ing that the DNA was completely degraded when treated
with hPLSCR1 as visualized on a 1 % agarose gel stained
with ethidium bromide; 12 % native PAGE was also used
to better resolve the products formed during the nucle-
ase reaction (Fig. 3b). hPLSCR1 incubated with genomic
DNA migrated with a retarded smear, thus confirming
the nuclease activity of hPLSCR1. Nuclease reaction was
then performed for different time periods (5, 10, 15, 30,
60, 90 min) at 37 °C. Time course study revealed that
the degradation of DNA happens as early as 10 min with
the complete degradation at 60 min for 200 ng of DNA
(Fig. 3c). Nuclease assay was also performed with total
RNA, plasmid DNA and single stranded DNA (ssDNA)
as substrates. hPLSCR1 exhibited nuclease activity in
dsDNA, RNA and but no nuclease activity was observed
when treated with ssDNA (Fig. 3d and e). Interestingly,
hPLSCR1 nicks the plasmid DNA as evident from the
figure as a single band is observed when plasmid DNA
is treated with hPLSCR1 (Fig. 3d). To further confirm
that the purified protein is devoid of other contaminat-
ing proteins (negative control), pET 28a (+) vector with-
out the insert was transformed in E. coli and the
purification protocol was repeated as described earlier.
SDS-PAGE analysis did not reveal any contaminating
proteins in the negative control and the resulting sample
did not have any nuclease activity (data not shown). This
revealed that the recombinant hPLSCR1 is not contami-
nated with host proteins, which could contribute to the
nuclease activity of hPLSCR1.
To reconfirm this, nuclease assay and Kunitz assay (as
described in 'Methods') was performed with heat inacti-
vated and trypsin treated hPLSCR1 and results confirmed
that nuclease activity was protein mediated as the genomic
DNA was not degraded when trypsin digested or heat inac-
tivated protein was used for the nuclease reaction (Fig. 4a
and b). Nuclease assay and Kunitz assay was performed
Fig. 2 Topo IIα decatenation assay in presence of hPLSCR1.
Decatenation assay was performed for topoisomerase IIα in the presence
of hPLSCR1 as described in 'Methods'. 200 ng of kinetoplast DNA (kDNA)
is treated with 1 U of topo IIα for 15 min at 37 °C and was then
visualized on a 1 % agarose gel. Control denotes negative control where
only kDNA is present. Lane 1 and lane 2 corresponds to the
decatenation assay performed with topo IIα pre-treated with 2 pmol of
hPLSCR1 and 20 pmol of hPLSCR1 respectively. Lane 3 corresponds to
the decatenation assay in the absence of topo IIα where only hPLSCR1
was added to kDNA
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with increasing hPLSCR1 concentrations (2 pmol, 5 pmol,
10 pmol, 15 pmol and 20 pmol). Results clearly explained
that there is a dose dependent increase in the nuclease
activity confirming that the nuclease reaction is dependent
on the concentration of hPLSCR1 (Fig. 4c and d).
Parameters affecting nuclease activity
We tested the effect of pH, temperature, cofactors and pro-
tein modifying reagents to characterize the nuclease func-
tion of hPLSCR1. hPLSCR1 exhibited maximum activity of
9297.3 U/mg at 37 °C and the activity reduced significantly
beyond 45 °C, which was confirmed by gel assay and Kunitz
assay (Fig. 5a and b). A decrease in enzyme activity of 96 %
and 40 % was observed when incubated at 25 °C and 45 °C
respectively. In contrast to temperature studies, hPLSCR1
was found to be active over a range of pH 6.0–9.0 with
maximum activity at 8.5 (Fig. 5c and d).
Nuclease reactions were set up in the presence of
different metal ions like Ca2+, Mg2+ and Zn2+. hPLSCR1
exhibited a maximum activity of 8828.83 U/mg in the
presence of Mg2+, whereas a 70 % decrease in activity
was observed with Zn2+ and no activity was observed in
the presence of Ca2+ (Fig. 6a and b). Different concen-
trations (5 mM, 10 mM, 15 mM and 20 mM) of Ca2+,
Mg2+ and Zn2+ were tested for nuclease activity.
Calcium did not exhibit activity at any concentration
(Data not shown) whereas there was no significant
change in nuclease activity values with increasing con-
centrations of Mg2+ and Zn2+ (Fig. 6c).
Effect of protein modifying reagents on nuclease activity
hPLSCR1 was treated with 4 mM of amino acid modifiers
– NEM (cysteine modifier), DEPC (histidine modifier),
AEBSF (serine modifier) and PG (arginine modifier) and
Fig. 3 Nuclease properties of hPLSCR1. a Nuclease assay for hPLSCR1 with yeast and human genomic DNA (gel assay): Nuclease assay was performed as
described in ‘Methods’ section. 20 pmol of hPLSCR1 (enzyme) was treated with 200 ng of yeast and human genomic DNA (substrate) in assay buffer at
37 °C for 60 min and visualized on 1 % agarose gel with ethidium bromide. b Native PAGE for visualization of nuclease activity (gel assay): 200 ng of
human genomic DNA was incubated with hPLSCR1 at 37 °C for 60 min and visualized on a 12 % native PAGE stained with 0.5 μg/ml ethidium bromide.
‘Ladder’ denotes 1 kb ladder. c Time dependent nuclease activity of hPLSCR1 (gel assay): hPLSCR1 (20 pmol) was incubated with human genomic DNA
(200 ng) at 37 °C for 5, 10, 15, 30, 60, 90 min along with a no-enzyme control (control) and visualized on 1 % agarose gel with ethidium bromide. d Effect
of substrates on nuclease activity (gel assay): Nuclease assays were performed with 200 ng of plasmid DNA and total RNA as substrates along with a
no-enzyme control visualized on a 1 % agarose gel. e Nuclease activity of hPLSCR1 with ssDNA (gel assay): Nuclease assays were performed with 200 ng
of a random ssDNA (43 bases) and dsDNA (human genomic DNA) along with a no-enzyme control containing both the substrates and visualized on a
2 % agarose gel
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checked for nuclease activity (Fig. 7a). Among all those
tested, DEPC treated hPLSCR1 showed 51 % inhibition
(3935.24 U/mg) whereas PG and NEM showed 40 and
45 % inhibition when compared to the untreated hPLSCR1.
This suggests that histidine, cysteine and arginine residues
are crucial for nuclease activity. AEBSF did not inhibit the
nuclease activity indicating that serine does not affect the
nuclease activity. A dose dependent inhibition was ob-
served when hPLSCR1 was treated with increasing
concentrations of DEPC (Fig. 7b). When the nucle-
ase assay was performed for an incubation time of
60 min, DEPC exhibited more inhibition than any
other reagent, which is in accordance with specific
activity values (Fig. 7c). In the absence of DEPC,
complete degradation of DNA similar to untreated
sample was observed. In the presence of DEPC, the
reaction was inhibited as seen by the smeared DNA
in the DEPC lane compared to the disappearance of
band in the other amino acid modifiers. Based on
Kunitz and gel assay results, it was found that DEPC
showed the most inhibition among the tested amino
acid modifiers.
Role of histidine residues in nuclease activity of hPLSCR1
Amino acid modifications of hPLSCR1 revealed that
DEPC, majorly a histidine modifier showed maximum in-
hibition of nuclease activity. hPLSCR1 has five histidines
(Fig. 8a) and all the five histidines (H12, H53, H111, H211,
H262) were mutated to alanine and the clone was named
as Mut-hPLSCR1. Mut-hPLSCR1 was then cloned, over-
expressed, purified and analyzed on a 12 % SDS-PAGE
using silver staining. A single band corresponding to
37 kDa was observed confirming the presence of Mut-
hPLSCR1 (Fig. 8b). In order to confirm that the point mu-
tations did not destabilize the structure of the protein, CD
studies were performed. Results revealed that Mut-
hPLSCR1 retained the alpha helical signature that was ob-
served in wild type (WT-hPLSCR1) thus showing that the
mutant protein is in its native form (Fig. 8c and d). Nucle-
ase assay was performed with Mut-hPLSCR1 and WT-
hPLSCR1. Results revealed that the nuclease activity was
relatively very low in Mut-hPLSCR1 compared to WT-
hPLSCR1 (Fig. 8e). Nuclease activity by gel assay with in-
creasing concentrations of Mut-hPLSCR1 showed that a
negligible nuclease activity even when the concentration
Fig. 4 Nuclease activity is protein mediated. a, b Nuclease assay upon protein inactivation: gel assay (a) and Kunitz assay (b) were performed with
heat-inactivated and trypsin digested hPLSCR1 (20 pmol) along with native hPLSCR1 (untreated) and a no enzyme control (control). c Effect of hPLSCR1
concentration on nuclease activity (gel assay): 200 ng of human genomic DNA was incubated with various concentrations of hPLSCR1 (2 pmol, 5 pmol, 10
pmol, 15 pmol and 20 pmol) at 37 °C for 60 min and visualized on a 1 % agarose gel stained with 0.5 μg/ml ethidium bromide. ‘Control’ denotes negative
control. d Kunitz assay was performed for varying concentrations of hPLSCR1 as described above. * denotes statistical significance at p< 0.05, ** denotes
statistical significance at p< 0.005; ns – not significant. Experiments were performed in triplicates and error bars denote standard deviation
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was increased by 3 fold (60 pmol) than normal assay
conditions (Fig. 8f). In addition, the nuclease activity of
Mut-hPLSCR1 was also quantified by Kunitz assays. At
low concentrations (2-10 pmol), nuclease activity was not
observed for Mut-hPLSCR1 and at higher concentrations
(20-60 pmol), 60 % loss in nuclease activity of Mut-
hPLSCR1 compared to WT-hPLSCR1 (Fig. 8g). The rem-
iniscent nuclease activity might be due to several other
factors, which need to be further investigated. These
results clearly explain that the histidine residues are vital
for nuclease activity of hPLSCR1.
Discussion
hPLSCR1 is a multifunctional protein involved in several
key cellular pathways such as cell cycle, apoptosis, Ca2+
homeostasis. In this study, we demonstrated that hPLSCR1
possesses novel function of nuclease activity for the first
time. Finding the physiological implications of the nuclease
activity of hPLSCR1 could pave way to identify new roles
for hPLSCR1 in several cellular processes. Even though
hPLSCR1 was reported to enhance the decatenation activity
of topo IIα, the underlying mechanism is not yet deci-
phered. hPLSCR1 could either (i) alter the structure of topo
IIα thereby leading to an increase in the catalytic activity;
(ii) help in unwinding or cleaving of the DNA substrate
bound to topo IIα; (iii) possess independent nuclease prop-
erties that aid in decatenation activity of topo IIα. To inves-
tigate this, the decatenation assay was performed with topo
IIα pretreated with 2 pmol and 20 pmol of hPLSCR1. At
low amounts of hPLSCR1, we observed enhancement of
decatenation activity similar to previous report [25]. When
20 pmol of hPLSCR1 was used in the decatenation assay, a
distinct band was observed along with the decatenation
products of topo IIα. The appearance of this unique band
was further confirmed by performing the decatenation
assay with hPLSCR1 in the absence of topo IIα explaining
that apart from enhancing the decatenation activity of
topoisomerases, hPLSCR1 could independently possess nu-
clease properties which could aid in the enhancing the cata-
lytic activity of topo IIα. Topo IIα is known to interact with
Fig. 5 Effect of temperature and pH on nuclease activity of hPLSCR1. a Temperature effect on nuclease activity (gel assay): hPLSCR1(20 pmol)
was incubated with human genomic DNA (200 ng) for 60 min at different temperatures such as 25, 30, 37, 40, 45, 50 °C along with a no-enzyme
control ‘Control’ and were visualized on a 1 % agarose gel. b Temperature effect on nuclease activity (Kunitz assay): Kunitz assay was performed
as described in ‘Methods’ section. The calculated specific activity values from Kunitz assay at various temperatures (25, 30, 37, 40, 45 °C) were
plotted. c pH effect on nuclease activity (gel assay): hPLSCR1 (20 pmol) was incubated with human genomic DNA (200 ng) for 60 min at different
pH such as 4.5, 5.5, 6.5, 7.5, 8.5, 9.0, 9.5 along with no-enzyme control named ‘Control’ and visualized on a 1 % agarose gel. d pH effect on
nuclease activity (Kunitz assay): Kunitz assay was performed as described under ‘Methods’ section. The calculated specific activity values from
Kunitz assay at various pH (6.5, 7.5 8.0, 8.5, 9.0, 9.5) were plotted. Experiments were performed at-least three independent times and error bars
denote standard deviation
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CAD nuclease and is involved in chromatic condensation.
The CAD nuclease apart from digesting DNA during apop-
totic execution, it also interacts with topo IIα and enhances
the decatenation activity of topo IIα in vitro [36]. In another
report, topo IIβ interacts with an extracellular nuclease in
mammalian spermatozoa and the interaction enhances the
decatenation activity of topo IIβ [37]. Similarly, we believed
that hPLSCR1 could have nuclease properties, which could
be the reason for enhancement of decatenation activity of
topo IIα in vitro. To support this hypothesis, sequence
alignment of hPLSCR1 with known nucleases with
bioinformatics tools revealed some key findings. PRD of
hPLSCR1 has vast similarities with the PRD of TREX1, a
mammalian member of DnaQ-like 3′–5′ exonuclease fam-
ily [38]. TREX1 exonuclease activity is supported by a metal
ion catalyzed phosphoryl transfer mechanism. TREX1 con-
stitutes about 45 prolines and its PRD contains about 6
prolines, which are involved in interactions with various
protein complexes [38, 39]. Sequence analysis showed that
about 16 out of 29 prolines in PRD of hPLSCR1 were
aligned and 4 prolines of TREX1 PRD exactly corresponded
with PRD of hPLSCR1 (Data not shown). The Mg2+
binding site (176ATEDMDCLT184) in human FLAP
endonuclease I (FEN1), a protein involved in DNA
replication and repair was also conserved in hPLSCR1
(142AAEDTDCCT150). The bold characters in the se-
quence indicate the residues involved in Mg2+ binding
in FEN1, which are conserved in hPLSCR1. Hence,
these striking similarities along with various other fac-
tors in the literature such as Mg2+ binding, up regula-
tion by interferons, involvement during apoptosis,
interaction and enhancement of decatenation activity
of topo IIα and processing of kDNA even in absence
of topo IIα intrigued us to elucidate the unique prop-
erty of hPLSCR1 as a nuclease.
Purified recombinant hPLSCR1 exhibited a dose
dependent nuclease activity when incubated with yeast gen-
omic DNA and human genomic DNA at 37 °C. Overex-
pression and purification was repeated for E. coli cells
transformed with pET 28a (+) vector without any insert
Fig. 6 Effect of metal ions on nuclease activity of hPLSCR1. a Gel assay: hPLSCR1 was incubated with human genomic DNA in the presence of
10 mM of CaCl2, MgCl2 and ZnCl2 at 37 °C for 60 min and visualized on a 1 % agarose gel. b Metal ions effect on nuclease activity (Kunitz assay):
Nuclease activity was calculated from Kunitz assay done for 10 mM of CaCl2, MgCl2 and ZnCl2 or in the absence of metal ions. c Dose dependence of
MgCl2 and ZnCl2 on nuclease activity of hPLSCR1. Kunitz assays were performed with 5 mM, 10 mM, 15 mM and 20 mM of MgCl2 and ZnCl2. *
denotes statistical significance at p < 0.05, ** denotes statistical significance at p < 0.005; *** denotes statistical significance at p < 0.0005; ns – not
significant. Experiments were performed in triplicates and error bars denote standard deviation
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(vector-purified protein). No distinct bands were revealed
in SDS-PAGE analysis of the vector-purified protein and
the samples did not show any nuclease activity (data not
shown). A random 37 kDa protein that was purified by the
same protocol as mentioned in ‘Methods’ was also tested as
a negative control to eradicate the possibilities of a co-
purified contaminating host nuclease because of the purifi-
cation protocol (data not shown). Absence of nuclease
activity in vector-purified sample and in random protein
clearly states that the nuclease activity is borne only by
hPLSCR1 and not by other host contaminating nucleases.
hPLSCR1 was active at temperatures between 25 and 45 °C
(Fig. 5a), where a temperature of 37 °C was found to be
optimum for its activity, which was similar for many other
human nucleases such as TREX1, FLAP endonuclease 1
(FEN 1) and DNase 1. The optimal pH for nuclease activity
was found to be between pH 8.0 and 9.0 (Fig. 5b) suggest-
ing that hPLSCR1 probably acts as an alkaline nuclease.
Most of the nonspecific nucleases such as TREX1 and
FEN1 had highest activity at 7.5 and 8.0 respectively [38,
40]. This was further confirmed by assaying nuclease
activity with various substrates such as ssDNA, dsDNA and
RNA. hPLSCR1 exhibited nuclease activity towards dsDNA
and RNA but not ssDNA. hPLSCR1 exhibited nicking ac-
tivity towards plasmid DNA which could explain that
hPLSCR1 might be a nicking endonuclease which needs to
be further investigated. TREX-1 digests ssDNA and dsDNA
with mismatched 3′ termini [41]. These findings suggest
that hPLSCR1 is a non-specific alkaline nuclease.
Majority of nucleases require metal ions such as Mg2+,
Ca2+ and Zn2+ for their activity. Metal ions in nucleases
are found to play a dual role: (i) enhancing the affinity of
the substrate to the enzyme which could be sequence or
structure specific and (ii) directly involved in catalysis
where the phosphate oxygen bond is cleaved [42]. To
verify the specificity of metal ions for nuclease activity of
hPLSCR1, assays were performed with Ca2+, Zn2+ and
Mg2+ (Fig. 6). Ca2+ did not induce nuclease activity,
which was astonishing as Ca2+ binding is vital for the PL
translocation by hPLSCR1 across the lipid bilayer. It was
found that Mg2+ and Zn2+ stimulated nuclease activity
and might possibly play a role in stabilizing the enzyme
Fig. 7 Effect of amino acid modifying reagents on nuclease activity of hPLSCR1. a Kunitz assay: Kunitz assay was used to calculate specific activity
of hPLSCR1 (20 pmol) treated with 4 mM of each of the amino acid modifiers including NEM, PG, DEPC, AEBSF along with native hPLSCR1
(untreated). Graph shows the percentage activity of modifier treated hPLSCR1 compared to the untreated hPLSCR1. b DEPC dose dependence
studies on nuclease activity: Kunitz assays were used to calculate specific activity of hPLSCR1 treated with an increasing concentration of DEPC
(2 mM, 4 mM, 8 mM, and 16 mM) and plotted. c Effect of protein modifying reagents on nuclease activity (gel assay): Nuclease assays for
hPLSCR1 treated with 4 mM of NEM, AEBSF, DEPC, and PG at 37 °C for 60 min were visualized in 1 % agarose gel. * denotes statistical
significance at p < 0.05, ** denotes statistical significance at p < 0.005; ns – not significant. Experiments were performed in triplicates and error
bars denote standard deviation
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structure apart from catalysis. hPLSCR1 has an EF hand
like Ca2+ binding motif and point mutations in the D275
resulted in loss of calcium binding and scramblase activ-
ity [30]. We also reported that Mg2+ binds to the EF
hand like Ca2+ binding motif in hPLSCR1 (D273 – D284)
[31]. Hence to understand the metal binding properties of
hPLSCR1, D275A point mutant of hPLSCR1 was gener-
ated and checked for scramblase activity and nuclease
activity. The mutant D275A-hPLSCR1 showed a complete
loss of scramblase activity, but the nuclease activity was
not affected (data not shown). This could possibly explain
that Mg2+ could have a binding site other than the EF-
hand like motif which remains to be investigated. Further
studies should be performed to understand the mechan-
ism of Mg2+ interaction with hPLSCR1.
Protein modification experiments revealed that histi-
dine, cysteine and arginine residues in hPLSCR1 were
important for nuclease activity. Histidines and cysteines
are the most commonly occurring active site residues in
nucleases. In a similar study, DEPC modification of CAD
nuclease inhibited the nuclease activity. CAD nuclease has
two histidine residues at its active site that is essential for
Fig. 8 Histidine residues are essential for nuclease activity of hPLSCR1. a Schematic showing the position of five histidine residues in hPLSCR1. F1-F6
and R1-R6 were the forward primers and reverse primers used for generation of mutations respectively. A detailed methodology for generation of
point mutants is described in 'Methods' section. b Silver stained SDS-PAGE gel showing 20 pmol of Mut-hPLSCR1 along with WT-hPLSCR1 purified to
homogeneity. Circular Dichroism studies for WT-hPLSCR1 (c) and Mut-hPLSCR1 (d) in the presence and absence of 3 mM MgCl2 were shown. e Nuclease
assay for Mut-hPLSCR1 (gel assay): Gel assay was performed for Mut-hPLSCR1 and WT-hPLSCR1 as described in ‘Methods’ section and visualized on a 1 %
agarose gel. f Dose dependence of Mut-hPLSCR1 by gel assay: Nuclease assay was performed at increasing concentration of Mut-hPLSCR1 (20 pmol,
40 pmol, 60 pmol) and visualized on a 1 % agarose gel. g Dose dependence studies for Mut-hPLSCR1 by Kunitz assay: Kunitz assay was performed to
quantify the nuclease activity of increasing concentrations of Mut-hPLSCR1 (20 pmol, 40 pmol, 60 pmol) (grey bars) and compared with the dose
dependent nuclease activity of WT-hPLSCR1 (white bars). ** shows statistical significance at p< 0.005; ns- not significant. Experiments were repeated at
least three independent times and the error bars denote standard deviation
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its nuclease activity. The active site of CAD possesses two
histidine residues and DEPC modification inactivated the
enzyme [43]. Based on our results, we generated a histidine
point mutant (Mut-hPLSCR1) where all the histidine resi-
dues in hPLSCR1 were mutated to alanine. Mut-hPLSCR1
showed a threefold decrease in nuclease activity only when
assayed at 20-60 pmol and showed statistically insignificant
activity at lower concentrations (2-10 pmol). This confirms
that the nuclease activity is only by hPLSCR1 and elimi-
nates the possibility of co-purification of a host contaminat-
ing nuclease. Histidine could be involved either in the
catalytic site or for stabilizing the enzyme substrate
complex which needs to be further investigated.
The mechanism and the physiological role of the nucle-
ase property of hPLSCR1 in normal and pathological
conditions remain to be investigated. In a recent report,
hPLSCR1 was shown to be induced and localized to PM
and periplasmic region upon dsDNA transfection in
normal immortalized ovarian surface epithelial cells [44].
The physiological relevance of this marked induction is not
yet identified. Since it is already well documented that
hPLSCR1 is a part of interferon mediated anti-viral defense,
the induced hPLSCR1 during dsDNA transfection might
have a role as a nuclease in defense against foreign DNA.
Conclusions
In summary, this is the first report showing a novel Mg2+
dependent activity of hPLSCR1. The nuclease activity was
strictly metal dependent and could act on dsDNA, RNA
but not ssDNA as substrates. DEPC treated hPLSCR1 ex-
hibited reduced nuclease activity and further mutation of
histidines resulted in a 60 % loss of activity. Histidines could
play a critical role in nuclease activity of hPLSCR1. Further
studies are required to ascertain the exact mechanism of
nuclease activity, critical residues involved in catalysis, Mg2
+ binding, substrate binding and the physiological relevance
for nuclease activity of hPLSCR1.
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